Effect of hydrogen gas inhalation on patient QOL after hepatectomy: protocol for a randomized controlled trial.
Masaki Kaibori, Hisashi Kosaka · Trials · 2021
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This publication examined hydrogen gas using the study design reported by the authoritative source. No study results are reported because this publication is a protocol.
Planned Hydrogen Intervention
In humans, hydrogen inhalation therapy is presently approved as a treatment under Advanced Medical Care B in Japan (jRCTs031180352: limited to adult patients who suffered out-of-hospital cardiac arrest and are in a continuous coma) and its effectiveness is being examined in a clinical trial. No report, however, has been made on ROS inhibition by hydrogen inhalation therapy or its effectiveness in post-hepatectomy patients. The subjects will be patients who will undergo hepatectomy and will be allocated randomly into group A with hydrogen gas inhalation or group B with air inhalation after hepatectomy.
Current Study Status
This publication describes a planned or ongoing study; H2HUBB presents it as a protocol rather than as completed outcome evidence.